If you're looking for digital biomarker development companies with FDA-cleared solutions for health research and treatment, Empatica is a top contender. Empatica's AI-powered suite of wearables, software and digital biomarkers continuously monitor health and can be used for research and treatment. Its FDA-cleared Health Monitoring Platform is highly scalable and adaptable to multiple therapeutic areas, offering a wealth of information about patients' health. Empatica has been used by pharmaceutical companies to develop new digital biomarkers and has secured 5 FDA clearances, so it's a good option for research and treatment.
Another contender is Tempus, which offers an AI-powered precision medicine platform to help improve cancer treatment. It offers tools like a clinical assistant, care gap identifier and multimodal real-world data analysis. The platform has FDA Breakthrough Device Designation and has been used to predict patient-specific drug responses, so it's a good option for personalized therapy and drug development.
If you need more general-purpose bioinformatics tools, QIAGEN Digital Insights offers a powerful platform for genomic and clinical research. The platform offers tools for annotating, filtering and triaging variants, as well as expert-curated solutions for biomarker and target discovery. With extensive integration abilities and a large knowledge base, QIAGEN Digital Insights is a good option for extracting useful information from patient data.